We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

70 hedge funds and large institutions have $83.2M invested in Alaunos Therapeutics in 2013 Q2 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $3.04M | Put options by funds: $1.72M

47.53% more ownership

Funds ownership: 0% → 47.53% (+48%)

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
2.28%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
$3.04M
Puts
$1.72M
Net Calls
+$1.32M
Net Calls Change
+$1.32M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

TCRT Hedge Fund Activity: Q2 2013 in Review

70 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2013, worth a combined $83.2M.

Buyers outnumbered sellers: 70 funds opened new TCRT positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

  • 70 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $83.2M of Alaunos Therapeutics stock for Q2 2013.
  • 70 funds opened new Alaunos Therapeutics positions in Q2 2013 and 0 closed out, a net change of +70 holders.

Based on aggregated 13F filings for Q2 2013.